Cincinnati Enquirer: In battling COVID-19, Gov. DeWine infuriated some fellow Republicans
Political scientist David Niven weighs in on DeWine’s political standing
Ohio Gov. Mike DeWine’s handling of the state during the pandemic could threaten his future run for governor, a UC expert tells the Cincinnati Enquirer.
"There’s an awful lot of people in his party who consider his leadership the last year to be an unforgivable sin," says David Niven, a political science associate professor at the University of Cincinnati.
Niven teaches American politics in UC's College of Arts and Sciences and conducts research on campaigns, political communication and death penalty policy.
Featured image at top of Gov. Mike DeWine visiting a vaccination site. Photo/Albert Cesare/The Enquirer.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.